HBM BioCapital II LP is 10% Owner at Allena Pharmaceuticals, Inc. (ALNA). They have made 1 open-market trade across 1 company since 2017, most recently 2017-11-06.
CIK 0001721496
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1000K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALNA | 1,566,902 | $118K |
Shares reported on the most recent Form 4, priced at the 2017-11-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALNA | BUY | 2017-11-06 | 2017-11-08 | $14.00 | $1000K | +9.2% | +24.3% | -32.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.